232 related articles for article (PubMed ID: 22232517)
21. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.
Wand H; Calmy A; Carey DL; Samaras K; Carr A; Law MG; Cooper DA; Emery S;
AIDS; 2007 Nov; 21(18):2445-53. PubMed ID: 18025881
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
23. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.
Macías J; Castellano V; Merchante N; Palacios RB; Mira JA; Sáez C; García-García JA; Lozano F; Gómez-Mateos JM; Pineda JA
AIDS; 2004 Mar; 18(5):767-74. PubMed ID: 15075511
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors.
Akl LD; Valadares ALR; Moraes MJ; Pinto-Neto AM; Lagrutta B; Costa-Paiva L
Braz J Infect Dis; 2017; 21(3):263-269. PubMed ID: 28284656
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
26. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
27. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon.
Pangmekeh PJ; Awolu MM; Gustave S; Gladys T; Cumber SN
Pan Afr Med J; 2019; 33():87. PubMed ID: 31489065
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome associated with HIV and highly active antiretroviral therapy.
Barbaro G; Iacobellis G
Curr Diab Rep; 2009 Feb; 9(1):37-42. PubMed ID: 19192423
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
30. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.
Kyeyune R; Saathoff E; Ezeamama AE; Löscher T; Fawzi W; Guwatudde D
BMC Infect Dis; 2014 Sep; 14():496. PubMed ID: 25209550
[TBL] [Abstract][Full Text] [Related]
32. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
[No Abstract] [Full Text] [Related]
33. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
34. Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy.
Lin KY; Liao SH; Liu WC; Cheng A; Lin SW; Chang SY; Tsai MS; Kuo CH; Wu MR; Wang HP; Hung CC; Chang SC
PLoS One; 2015; 10(9):e0137660. PubMed ID: 26360703
[TBL] [Abstract][Full Text] [Related]
35. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
[TBL] [Abstract][Full Text] [Related]
36. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
37. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
38. [Hypertension and metabolic syndrome in HIV infected patients].
Zanuzzi MG; Cattaneo MJ; López SM; Pérez Maure MLÁ; Romero CA
Medicina (B Aires); 2020; 80(5):453-461. PubMed ID: 33048789
[TBL] [Abstract][Full Text] [Related]
39. Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.
Crum-Cianflone NF; Weekes J; Bavaro M
AIDS Patient Care STDS; 2008 Oct; 22(10):771-8. PubMed ID: 18783326
[TBL] [Abstract][Full Text] [Related]
40. Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.
Freitas P; Carvalho D; Souto S; Santos AC; Xerinda S; Marques R; Martinez E; Sarmento A; Medina JL
BMC Infect Dis; 2011 Sep; 11():246. PubMed ID: 21933422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
